Medicure (TSE:MPH) has released an update.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Medicure Inc. reported a decrease in total net revenue to $5.2 million in Q2 of 2024, down from $6.0 million in the same quarter the previous year, with significant drops in sales from its AGGRASTAT product due to increased generic competition. The company also experienced a net loss of $1.2 million, a stark contrast to the net income of $253,000 reported in Q2 of 2023.
For further insights into TSE:MPH stock, check out TipRanks’ Stock Analysis page.